Why are you looking at Emes2 Pharmaceuticals?
Capability
Service linesALL OTHER SUPPORT SERVICES
Work mix: 100% prime · 0% sub · primary NAICS 562211 / PSC P100 SALVAGE- PREPARATION AND DISPOSAL OF EXCESS/SURPLUS PROPERTY
Where they win
3 agenciesRecompete exposure: None
No incumbent recompetes detected in the next 24 months.
Agency buyer map
3 buyersRecompete exposure
NoneNo incumbent recompetes detected in the next 24 months.
No incumbent recompetes detected in the next 24 months.
GET THE FULL BRIEF
Get Emes2 Pharmaceuticals’s recompete exposure, top agencies and teaming history
The outlook above is free to read and verify — an estimated $205K in play. Enter a work email for two figures the page cannot show.
“After 35 years in federal contracting, I've seen what separates the firms that win from the ones that wonder why they lost. What SCOUT does is put the kind of competitive and market intelligence in front of BD teams…”
Enter your company name and we'll build the page.
Query this company live in SCOUT via MCP — personalized displacement scoring, alerts, and capture workflow. Learn about SCOUT MCP →
Frequently asked questions
What federal contracts does Emes2 Pharmaceuticals hold?
Emes2 Pharmaceuticals (UEI L9BAWRKDMLD4) shows $205K across 18 award actions in SCOUT’s public USASpending-backed profile, with Department of Health and Human Services (HHS) as the top buying agency. Totals cover federal prime awards ≥$100K in the rolling window.
Which agencies does Emes2 Pharmaceuticals work with?
Emes2 Pharmaceuticals’s firm-wide obligated mix is led by Department of Health and Human Services (HHS) (67%), Department of Veterans Affairs (VA) (23%), Department of Justice (DOJ) (11%).
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Explore it live — $90 Pilot →